Alan W. Schoenbart
A CPA, a senior executive with more than thirty years of financial management experience, CEO & CFO, Echo Therapeutics, fmr. CFO Hudson News, fmr. CEO & CFO Forticell Bioscience, Inc., a publicly-traded medical device company with an FDA approved product. He was the CFO of Vizacom Inc., publicly traded IT company. He has extensive experience in SEC reporting, budgeting, forecasting, stocks and debt offerings, investor relations, accounting and internal control systems, as well as administrative and operational expertise. Mr. Schoenbart has a BS in accounting and is a Certified Public Accountant licensed in the State of New York and the State of New Jersey.).